[How to prescribe topical antibiotics in ophthalmology].
Given the increase in bacterial resistance, antibiotics use has been carefully studied during the last decade. In France, topical antibiotics have therefore been restricted to medical prescription, and specific guidelines were published by the French Agency for the Safety of Healthcare Products (AFSSAPS) in 2004. This article reviews the literature on emerging bacterial resistance in ophthalmology, and summarizes the AFSSAPS guidelines.
Robert
P-Y
PY
Service d'Ophtalmologie, CHU Dupuytren, Limoges, France. pierre-yves.robert@unilim.fr
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D001762:Blepharitis / Q000188:drug therapy / Q000382:microbiology; D003234:Conjunctivitis, Bacterial / Q000188:drug therapy / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D006801:Humans; D007634:Keratitis / Q000188:drug therapy / Q000382:microbiology; D009885:Ophthalmology / Q000592:standards*; D017410:Practice Guidelines as Topic
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local